Aperio Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$19.3M Buy
123,557
+3,730
+3% +$583K 0.06% 322
2020
Q3
$13.7M Sell
119,827
-19,143
-14% -$2.19M 0.05% 374
2020
Q2
$15.6M Buy
138,970
+41,827
+43% +$4.69M 0.06% 324
2020
Q1
$8.72M Buy
97,143
+32,956
+51% +$2.96M 0.04% 457
2019
Q4
$6.94M Sell
64,187
-1,052
-2% -$114K 0.02% 607
2019
Q3
$6.39M Sell
65,239
-4,325
-6% -$424K 0.03% 624
2019
Q2
$9.11M Sell
69,564
-4,831
-6% -$633K 0.04% 501
2019
Q1
$10.1M Buy
74,395
+4,911
+7% +$664K 0.04% 460
2018
Q4
$6.77M Sell
69,484
-4,123
-6% -$401K 0.03% 529
2018
Q3
$10.2M Sell
73,607
-14,828
-17% -$2.06M 0.05% 434
2018
Q2
$11M Buy
88,435
+16,513
+23% +$2.05M 0.05% 400
2018
Q1
$8.02M Buy
71,922
+8,740
+14% +$974K 0.04% 504
2017
Q4
$7.56M Sell
63,182
-8,446
-12% -$1.01M 0.04% 502
2017
Q3
$10M Buy
71,628
+12,109
+20% +$1.7M 0.06% 391
2017
Q2
$7.24M Sell
59,519
-15,912
-21% -$1.94M 0.04% 466
2017
Q1
$9.15M Buy
75,431
+676
+0.9% +$82K 0.06% 361
2016
Q4
$9.15M Buy
74,755
+17,244
+30% +$2.11M 0.07% 326
2016
Q3
$7.05M Sell
57,511
-12,679
-18% -$1.55M 0.05% 431
2016
Q2
$8.2M Buy
70,190
+7,569
+12% +$884K 0.06% 345
2016
Q1
$8.72M Sell
62,621
-6,023
-9% -$839K 0.07% 306
2015
Q4
$13.1M Buy
68,644
+12,668
+23% +$2.42M 0.12% 195
2015
Q3
$8.75M Buy
55,976
+3,576
+7% +$559K 0.09% 274
2015
Q2
$9.47M Buy
52,400
+4,164
+9% +$753K 0.1% 250
2015
Q1
$8.36M Buy
48,236
+2,435
+5% +$422K 0.09% 263
2014
Q4
$8.48M Buy
45,801
+2,981
+7% +$552K 0.1% 233
2014
Q3
$7.1M Buy
42,820
+2,173
+5% +$360K 0.1% 263
2014
Q2
$6.35M Buy
40,647
+2,783
+7% +$435K 0.09% 272
2014
Q1
$5.76M Buy
+37,864
New +$5.76M 0.08% 313
2013
Q4
Sell
-28,456
Closed -$3.31M 371
2013
Q3
$3.31M Buy
28,456
+5,400
+23% +$627K 0.06% 401
2013
Q2
$2.13M Buy
+23,056
New +$2.13M 0.05% 477